Skip to main content
OpenTrials

Clinical trial condition

Exocrine Pancreatic Insufficiency

Explore clinical trials studying Exocrine Pancreatic Insufficiency. Study availability and eligibility vary by location and protocol.

105 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Exocrine Pancreatic Insufficiency trial results

Completed

Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study

NCT02750501

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Diabetes Mellitus, +11 more
Locations
  • Joe DiMaggio Children's Hospital / Memorial Healthcare System Hollywood, Florida, United States
  • St. Luke's CF Center of Idaho Boise, Idaho, United States
  • Riley Hospital for Children at Indiana University Health Indianapolis, Indiana, United States
  • Maine Medical Center Portland, Maine, United States
View Trial Details
Completed

SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis

NCT02279498

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +6 more
Locations
  • Investigator Site 123 Long Beach, California, United States
  • Investigator Site 107 Los Angeles, California, United States
  • Investigator Site 114 Aurora, Colorado, United States
  • Investigator Site 120 Gainesville, Florida, United States
View all 54 locations
View Trial Details
Completed

EASY: Extended Access to Sollpura Over Years

NCT02823964

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +6 more
Locations
  • Investigator Site 114 Aurora, Colorado, United States
  • Investigator Site 134 Jackson, Mississippi, United States
  • Investigator Site 121 Burlington, Vermont, United States
  • Investigator Site 501 Brno, Czechia
View all 15 locations
View Trial Details
Completed

SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis

NCT02734810

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +6 more
Locations
  • Investigator Site 139 Little Rock, Arkansas, United States
  • Investigator Site Orange, California, United States
  • Investigator Site 114 Aurora, Colorado, United States
  • Investigator Site 117 Altamonte Springs, Florida, United States
View all 21 locations
View Trial Details
Completed

PR-018: An Open-Label, Safety Extension of Study PR-011

NCT01131507

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +6 more
Locations
  • Nemours Children's Clinic Jacksonville, Florida, United States
  • Children's Lung Specialists Ltd. Las Vegas, Nevada, United States
  • Akron Children's Hospital Akron, Ohio, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Completed

Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)

NCT00513682

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +13 more
Locations
  • University of Michigan Health System Cystic Fibrosis Center Ann Arbor, Michigan, United States
  • Cystic Fibrosis Center Rainbow Babies and Children's HospitalDivision Cleveland, Ohio, United States
  • Pennsylvania State University And the Milton S. Hershey Medical Center Hershey, Pennsylvania, United States
View Trial Details
Completed

Safety and Efficacy Study of ULTRASE® MT20 in Participants With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)

NCT00408317

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +6 more
Locations
  • DeVos Children's Hospital Grand Rapids, Michigan, United States
  • Rainbow Babies & Children's Hospital Cleveland, Ohio, United States
  • Pennsylvania State University, The Milton S. Hershey Medical Center Hershey, Pennsylvania, United States
  • University of Utah Health Sciences Center Salt Lake City, Utah, United States
View Trial Details

Related conditions